Tα1 increased the percentage of CD4+CD25+Foxp3+ (suppressive antitumor-specific Tregs), Tregs, IL-1β, TNF-α, and IL-6 in patients with gastric carcinoma. This evidence concerns the gene FOXP3 and gastric carcinoma.